electroCore, Inc. (NASDAQ: ECOR) Files An 8-K Other EventsItem 8.01Other Events.
On November 28, 2018, electroCore, Inc. issued a press release announcing FDA clearance for its gammaCore™ (non-invasive vagus nerve stimulator (nVNS)) therapy for adjunctive use for the preventive treatment of cluster headache in adults.A copy of the press release is filed herewith as Exhibit 99.1 and incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
electroCore, Inc. ExhibitEX-99.1 2 ecor-ex991_17.htm EX-99.1 ecor-ex991_17.htm Exhibit 99.1 electroCore Recieves FDA Clearance for gammaCore™ (nVNS) for Adjunctive Use for the Preventive Treatment of Cluster Headache in Adults Basking Ridge,…To view the full exhibit click here